Clinical value of MRI DWI and (Gd-EOB)-DTPA to assess liver involvement in patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Abstract #163

Introduction: Standard MRI, including breath-hold techniques with SE T1 and T2 weighted images, biochemical shift, and 3D GRE and also T1 images after gadolinium enhancement Gd-DTPA, are useful in detecting liver lesions in patients with advanced GEP-NET. Recently, new algorithms of MRI, including diffusion-weighted imaging MRI (DWI) and i.v. (Gd-EOB)-DTPA (Primovist) contrast enhancement, seems to be promising in the detection of liver deposits.
Aim(s): The detection rate of liver metastasis in patients with advanced GEP-NET, using standard SE T2 weighted images, compared to new algorithms diffusion-weighted imaging (DWI) and MRI after i.v. contrast enhancement (Gd-EOB)-DTPA.
Materials and methods: Study group 36pts, all had confirmed neuroendocrine tumors (GEP-NET), mean age 55.4 yrs, there were 20 females and 16 males. All had CS IV with liver involvement. All had MRI examination as a part of the standard clinical evaluation of disease extent (staging and restaging) and also to assess efficacy of therapy. All had PRRT using 90Y DOTATATE, 24 had previous and current ""cold"" analogues SST therapy. All pts had examinations using the same system 1.5T MRI, using the same protocol with DWI and other sequences of examination. Standard dose of contrast agent (Gd-EOB)-DTPA was used in each case, with administration recommended by manufactures.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Jaroslaw B Cwikla

To read results and conclusion, please login ...

Further abstracts you may be interested in

#987 Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional MRI in Pancreatic Neuroendocrine Tumors and Comparison with 68Ga-DOTANOC PET/CT
Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size and have variable prognosis related to grading and staging.
Conference: 11th Annual ENETS Conference (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Maria Gabriella Brizi
#1031 A Comparative Study Among Several Imaging Methods for the Detection of Primary and Metastatic Sites of GEP-NETs.
Introduction: GEP-NETs staging are essential for any therapeutic manipulation
Conference: 12th Annual ENETS Conference (2015)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD,PhD Dimitrios Dimitroulopoulos
Keywords: GEP-NET, staging
#1330 Pancreatic Neuroendocrine Neoplasms: Magnetic Resonance Imaging Features and Correlation with Their Histological Grade
Introduction: Pancreatic neuroendocrine neoplasms (PanNENs) have different biological behavior and prognosis according to their histological grade. At present, few data are available regarding the value of imaging techniques in predicting the grade of PanNENs.
Conference: 13th Annual ENETS conference (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Riccardo De Robertis
#2003 Comparison of Glucagon-Like-Peptide-1 (GLP-1) Receptor PET/CT, SPECT/CT and 3T MRI for the Localisation of Insulinomas: Evaluation of Accuracy in a Prospective Crossover Imaging Study
Introduction: Benign insulinomas are the most prevalent cause of endogenous hyperinsulinaemic hypoglycaemia (EHH) in adults and due to their small size difficult to localise.
Conference: 15th Annual ENETS conference (2018)
Category: Imaging and Interventions (radiology, endoscopy)
Presenting Author: Dr. Antwi Antwi
Authors: Antwi A, Heye T, Fani M, Nicolas G, ...
#59 Incidence and clinical significance of adrenal masses in patients with gastrenteropancreatic neuroendocrine tumors
Introduction: The widespread application of modern imaging modalities, mainly computerized tomography (CT) and magnetic resonance imaging (MRI), has revealed a 2-3% incidence of inadvertently discovered adrenal masses, the majority of which are non-functioning benign adrenal adenomas. In the presence of a known malignancy, such lesions have a more than 30% incidence of being metastases. As patients with gastrenteropancreatic neuroendocrine tumors (GEP-NETS) have mainly well-differentiated and slow-growing tumors and are subject to routine abdominal imaging for disease staging or during follow-up, it is important to study the incidence and significance of such lesions based on the recently introduced TNM classification system.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Georgios Kanakis